Itafos Inc., together with its subsidiaries, produces and sells phosphate and specialty fertilizers in the United States, Brazil, and Guinea-Bissau. The company operates through three segments: Conda, Arrais, and Development and Exploration. It offers monoammonium phosphate, monoammonium phosphate with micronutrients, superphosphoric acid, merchant grade phosphoric acid, ammonium polyphosphate, and hydrofluorosilicic acid. The company also provides single superphosphate, single superphosphate with micronutrients, sulfuric acid, acidulated phosphate rock, and direct application phosphate rock. In addition, it is involved in the operation of high-grade phosphate mine and fertilizer plant projects. The company is headquartered in Houston, Texas.
Research context
Itafos appears in PyInvesting’s TSX Venture Stock catalogue. The price history above describes this recorded instrument; it does not by itself identify a company’s business or establish a continuous investment return.
- Currency
- CAD
- Sector
- Basic Materials
- Industry
- Agricultural Inputs
These are the latest stored catalogue classifications, not a historical classification snapshot. An issuer description, classification effective date or currency may be unavailable. Check the issuer’s own disclosures and the observation dates before using these fields for research.
Review backtest assumptions and evidence before treating a chart or stored history as a research result.
5 years, 6 months ago
Itafos is currently in a long term uptrend where the price is trading 163.9% above its 200 day moving average.
From a valuation standpoint, the stock is 99.9% cheaper than other stocks from the Basic Materials sector with a price to sales ratio of 0.4.
Itafos's total revenue sank by 7.8% to $75M since the same quarter in the previous year.
Its net income has increased by 88.5% to $-10M since the same quarter in the previous year.
Finally, its free cash flow grew by 120.7% to $3M since the same quarter in the previous year.
Based on the above factors, Itafos gets an overall score of 4/5.